Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

SaltX Technology granted European solar collector patent

Nasdaq First North-Listed SaltX Technology has been granted a patent for its second-generation solar collector by the European Patent Office (EPO). It is based on the same low-cost version now being manufactured in China. The patent enables SaltX to intensify marketing of SunCool on the European market. The Solar collector stores thermal solar energy during the day and releases the heat and cold during the night.SaltX is collaborating since long with the leading thermal solar collector manufacturer in Poland – Hewalex - who has manufactured and delivered collectors to the SunCool reference

Thomas Ekman new President and CEO of Dustin

The Board of Directors of Dustin has appointed Thomas Ekman to new President and CEO. He will assume the position as per 1 January 2018.Thomas Ekman joins from Cabonline Group where he has had the role as CEO and has before that, inter alia, been CEO of Tele2 Sweden and is today member of the board of directors of Com Hem. He succeeds Georgi Ganev who leaves his position by the year-end, as previously announced. - With his experience of running complex businesses and building digital brands Thomas is the right person to lead Dustin’s continued development in the Nordic market and in line

ASTRAZENECA PLC ANNOUNCES TAGRISSO GRANTED BREAKTHROUGH THERAPY DESIGNATION BY US FDA

Designation based on positive Phase III FLAURA trial resultsSixth Breakthrough Therapy Designation for an AstraZeneca New Oncology medicine9 October 2017 07:00 BST TAGRISSO GRANTED BREAKTHROUGH THERAPY DESIGNATION BY US FDA FOR THE 1ST-LINE TREATMENT OF PATIENTS WITH EGFR MUTATION-POSITIVE NON-SMALL CELL LUNG CANCER AstraZeneca today announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) for Tagrisso (osimertinib) for the 1st-line treatment of patients with metastatic epidermal growth factor receptor (EGFR) mutation-positive non-

MUNTERS APPOINTS PRESIDENT INNOVATION

Munters (NASDAQ: MTRS) has appointed Paul Dinnage as President Innovation and Technology.In this role, Paul will lead the global Core Technology Function for Munters and play a key role in shaping the innovation and technology agenda across Munters. He will do this in close collaboration with the Business Areas, Global Operations and Global Services. Paul has a wealth of experience and is recognized in the industry as a technology leader. He started with Munters in 1985 as process engineer in the rotor plant in Amesbury, MA. During his career with Munters he has worked in Operations,

Handelsbanken’s interim report for January-September 2017 will be presented on October 18

Handelsbanken will present its results for January­‑September 2017 in Stockholm on October 18, 2017, at 8:30 a.m. CET, at a meeting with the media and analysts. The interim report for January‑September 2017 will be published at 7:00 a.m. CET, on October 18, 2017. A telephone conference will be held at 11:00 a.m. CET (5:00 a.m. EST), whenRolf Marquardt, CFO, will present and comment on the results. There will also be time for questions from the participants. UK number: +44 203–364 5374Swedish number: +46 8–505 564 74US number: +1 855–753 2230 Instructions1.    Dial

Safe to treat dementia patients with clot-busting drugs

[PRESS RELEASE 2017-10-09] Stroke patients with dementia treated with intravenous thrombolysis using powerful clot-busting drugs are at no higher risk of brain haemorrhage or death than other patients receiving the same treatment, a study from Karolinska Institutet published in the journal Neurology reports.Ischemic stroke is the most common form of stroke and is caused when a blood clot blocks the blood flow to the brain. Treatment with intravenous thrombolysis (IVT) using powerful clot-busting drugs within 4.5 hours of onset can greatly improve the prognosis and reduce the likelihood of

Wallenstam converts co-op apartment project in Solberga into rental apartments

Wallenstam will convert the first phase of the co-op apartment project Orangeriet in Solberga involving 90 apartments into rental apartments. The apartments are now under construction and are expected to be ready for occupation by spring 2018.“We feel that the situation in the cooperative apartment market in Stockholm is a little uncertain right now. We have therefore chosen to change the first phase of Orangeriet into rental apartments after conducting a market test of the project where we noted that the co-op apartment market has cooled down. Thanks to our cost-efficient new production

GomSpace secures new innovation project from Innovation Fund Denmark

Innovation Fund Denmark has awarded GomSpace A/S - a subsidiary of GomSpace Group AB (the ”Company”) and a consortium comprising 2Operate A/S and Aarhus University an R&D contract to develop network management technology targeting operations and management of large satellite constellations. The contract value for GomSpace is 2.500.000 DKR and the project will be executed over 24 months. For more information, please contact:Niels Buus (CEO)Tel: +45 40 31 55 57Email: nbu @ gomspace.com About Gomspace Group AB The Company’s business operations are mainly conducted through the

Clinical potential of C21 highlighted in review publications

Vicore Pharma (publ) (ticker VICO) has today published an updated reference list on the latest studies with the drug candidate C21. Three recent review articles, from Australia, Denmark/Florida and India respectively, summarize the pharmacological effects of C21 in specific indication areas. The conclusion of these reviews is that C21 has the potential to become a valuable addition to current medical treatment in several patient categories: as an anti-fibrotic agent for several indications, as a blood-pressure lowering agent in resistant hypertension, and as a nephroprotective medication for

Multiconsult ASA – Repurchase of own shares

On 6 October 2017, Multiconsult ASA ("Multiconsult") purchased 8 500 of its own shares at an average price of NOK 86.44 per share. The shares were purchased in accordance with the Company's share repurchase programme as announced on 22 September 2017. The shares were acquired on Oslo Børs.Following this transaction Multiconsult holds 51 645 of its own shares. For further information, please contact: Investor relations:      Mirza Koristovic, Head of Investor Relations      Phone: +47 93 87 05 25      E-mail: ir@multiconsult.no  Media:            Gaute Christensen, VP

Change in YIT Management Board

YIT Corporation Stock Exchange Release October 9, 2017 at 8:00 a.m.Tero Kiviniemi, Executive Vice President of YIT, has announced to resign from the company. YIT Corporation’s Board of Directors has nominated Chief Financial Officer Esa Neuvonen to act as Executive Vice President, and Timo Lehmus as Head of Business Premises and Infrastructure segment until the execution of the merger of YIT and Lemminkäinen. Both appointments are effective as of October 9, 2017. “Tero Kiviniemi has had an essential role in creating a strong YIT culture and in different managerial positions during his

Gunnebo Group Announces Preliminary Operating Profit for Quarter Three, 2017

The Gunnebo Group’s operating profit for the third quarter 2017 is expected to be weaker than the third quarter of 2016. The result derives mainly from three areas: ·  Region Americas: mainly due to lower sales to US public authorities, as well as from the severe weather conditions in the US and the earthquake in Mexico during September.    · South Africa: where a decision to close the underutilised manufacturing unit has been made during the quarter, allowing the South African business to have full focus on sales development. The closure affects some 100 employees. · France:

Major League Baseball Players Alumni Association Brings Legends for Youth Baseball Clinic Series to Venice, FL

Free youth baseball clinic to feature Michael Devereaux, Dave LaPoint and other MLB AlumniColorado Springs, Colo. – Local youth will have an opportunity to play with their big league heroes at the Major League Baseball Players Alumni Association (MLBPAA) Legends for Youth baseball clinic series on Wednesday, October 11th, 2017. The free clinic features former Major League Baseball players who will teach baseball skills, drills and life lessons for approximately 200 local youth.   Players attending* include 1995 Atlanta Braves World Series champion and 1995 NLCS MVP Michael Devereaux

Major League Baseball Players Alumni Association Brings Legends for Youth Baseball Clinic Series to Clearwater, FL

Free youth baseball clinic to feature Dave LaPoint, Tom Niedenfuer and other MLB AlumniColorado Springs, Colo. – Local youth will have an opportunity to play with their big league heroes at the Major League Baseball Players Alumni Association (MLBPAA) Legends for Youth baseball clinic series on Tuesday, October 10th, 2017. The free clinic features former Major League Baseball players who will teach baseball skills, drills and life lessons for approximately 200 local youth.   Players attending* include 1982 St. Louis Cardinals World Series champion Dave LaPoint and 1981 Los Angeles

New large TITAN® order for the North American industrial sector

Hexagon Composites' subsidiary Hexagon Lincoln announces a follow-on purchase order for TITAN® 4 trailers from Certarus Ltd. with a total value of USD 11 million (around NOK 86 million). The Mobile Pipeline® modules will serve the industrial sector in North America. Earlier this year, Hexagon and Certarus, a leading provider of fully integrated compressed natural gas (CNG) delivery solutions, entered into a long-term agreement. With this order Certarus is expanding its already large TITAN® fleet, which serves the oil and gas, industrial and commercial sectors. "The macro trend of

UTA develops cutting-edge lubricant technologies that can improve gas mileage while reducing wear and emissions

Researchers at the University of Texas at Arlington have developed a pipeline of new vehicle lubricant technologies that lower greenhouse gas emissions, reduce wear and improve gas mileage, as part of an 18-year collaboration with ESL TEKnologies and its predecessor companies in Dallas. “This is a really good example of business leveraging knowledge and know-how at the university to develop new products over the long term,” said Pranesh Aswath, UTA professor of Materials Science & Engineering and Mechanical & Aerospace Engineering. “The University also benefits through sustained

Competition authorities approve Gränges’ investment in GETEK GmbH

Gränges’ investment in the production company GETEK GmbH, that was announced on August 29, 2017, has received approval from the competition authorities. Gränges will invest in GETEK GmbH together with German Erbslöh Aluminium GmbH to produce aluminium billets utilizing advanced spray-forming technology. For Gränges the investment provides opportunities to expand within Active Brazing with products such as TRILLIUM®, an innovative technology that enhances the production and performance of brazed aluminium heat exchangers. Gränges invests EUR 4.4 million in cash for 51 percent of GETEK

Services are returned to normal operation

EVRY has now corrected the fault, and services were functioning as normal again from 23:45 on Friday 6. October.EVRY maintains a high readiness in order to ensure that everything goes to plan, and the company will monitor the situation throughout the night and the whole weekend."EVRY strongly regrets the error that has occurred and the inconvenience this has caused to our customers and their users. EVRY will, after the incident, carefully review the causal relationship and consider what measures will be taken to prevent such events from happening again, "says Björn Ivroth, CEO of

UTA wins grant to continue veteran success program

The U.S. Department of Education awarded a five-year, $1.3 million grant to The University of Texas at Arlington to renew funding for the University’s highly successful Veterans Upward Bound program. Veterans Upward Bound is an effort to improve college readiness and degree completion for those who served active duty in the U.S military. The program is offered on select college campuses nationwide and allows qualified veterans to receive free services such as counseling, mentoring, tutoring and academic instruction in core subject areas with the goal being to increase the rate at which

Tero Kivisaari resigns Nurminen Logistics’ Board of Directors

Nurminen Logistics Plc                           Stock Exchange Release 6 October 2017 at 5.15 pm    Tero Kivisaari has today notified Nurminen Logistics Plc that he will resign the company’s Board of Directors. He will resign from the Board with immediate effect. The Board of Directors continues to operate with four members until the next Annual General Meeting. Nurminen Logistics Plc Board of Directors For more information, please contact: Olli Pohjanvirta, Chairman of the BoardTel. +358 40 900 6977 DISTRIBUTION

Raute Corporation - Managers' transactions - Tapani Kiiski

RAUTE CORPORATION MANAGERS' TRANSACTIONS 6 October 2017 at 4:50 p.m.Raute Corporation - Managers' Transactions – Tapani Kiiski____________________________________________ Person subject to the notification requirementName: Kiiski, TapaniPosition: Chief Executive OfficerIssuer: Raute OyjLEI: 743700G00629V99PE435 Notification type: INITIAL NOTIFICATIONReference number: 743700G00629V99PE435_20171006160455_2____________________________________________ Transaction date: 2017-10-06Instrument type: SHAREISIN: FI0009004741Nature of the transaction: SUBSCRIPTION(X)

Eltel completes the divestment of its business operations in Estonia

Eltel’s sale of its business operations in Estonia to Estonian Tecnolines OÜ, announced on 30 August 2017, has now been approved by the Estonian Competition Authorities and the transaction has consequently been completed.The final transaction price amounts to roughly EUR 3 million with cash flow impact estimated at approximately EUR 2.5 million in the fourth quarter of 2017. This is, however, subject to additional expected payments based on changes in working capital. The transaction will have a negative impact of approximately EUR 1 million on Group EBITA and Eltel will record goodwill

Lagercrantz’ share based incentive programme fully subscribed

The incentive programme resolved by the 2017 Annual General Meeting for managers and members of senior management in Lagercrantz Group on call options to purchase class B shares held in treasury was fully subscribed. Approximately 50 managers in the Group acquired 675 000 options. The call options are transferred at a price of SEK 6.90 per call option, equivalent to the market value according to a valuation performed by Nordea Bank AB (publ). The exercise price amounts to SEK 95.30 (which is equivalent to 120 percent of the average market price during the measuring period 4 September –

Regarding Patent Applications

Cyxone has licensed patent applications at various stages of approval in Europe, North America and Australia. In the US, our patent is approved and in other markets patent applications are well on the way to being approved. In Australia, our patent application was accepted in July, since when the company has submitted a final version and paid the required approval fee.On October 5, the Australian patent office published a "certificate of grant". This means that our patent application is approved and that the agency is now able to issue a patent letter. Patent protection in this case lasts

There are no items matching the current filter
There are no more items matching the current filter
Back to top